22Nov
22Nov
Medical Robotics Firm Myomo Explores Going Public
Myomo, Inc., a commercial-stage medical robotics company whose products enable users to overcome upper extremity paralysis (www.myomo.com), announced today that it has confidentially submitted a Form 1-A with the Securities and Exchange Commission (SEC) relating to the proposed initial public offering of its common stock under the recently amended provisions of Regulation A pursuant to the Jumpstart Our Business Startups (JOBS) Act of 2012. The number of shares to be offered and the price range for the proposed offering have...
19Nov
Medical robotics firm treating upper extremity paralysis explores going public
Cambridge, Massachusetts-based Myomo announced Friday that it is taking advantage of new SEC provisions that allow early-stage companies to raise capital without restricting it to only accredited investors Through the Regulation A+ provision, which is an amendment to Regulation A, the Securities & Exchange Commission adopted rules that went into effect June 2015 allowing early-stage companies to raise a maximum of $50 million from the public. They are known as mini-IPOs and mark a pivotal moment given the agency accepted equity crowdfunding...
19Nov
Myomo Files for Reg A+ Offer. Expects to List on NYSE Following Funding Round
Myomo, a medical robotics company whose products enable users to overcome upper extremity paralysis, has filed a Form 1-A with the SEC indicating its intent to raise money under Reg A+, a crowdfunding exemption that allows issuers to seek up to $50 million in capital. Read more >>
19Nov
Myomo registers for IPO
Myomo said today it filed with the SEC for an initial public offering, looking to register on the NYSE under the ticker symbol “MYO”. Myomo develops and produces myoelectric orthotics for patients with neuromuscular disorders, including its flagship MyoPro line. The orthosis devices are non-invasive, powered braces used to support weak or deformed arms and hands to allow for functional activity. Read more >>
18Nov
Regroup Mass Notification Partners with Alvarez Associates
Regroup Mass Notification, the award-winning leader in emergency and day-to-day communication technology, today announced joint alliance with Alvarez Associates, an industry leader in workplace violence prevention. Read more >>
17Nov
Sysmex Selects Aras Innovator PLM
Aras, the next leader in enterprise product lifecycle management (PLM) software, announced Sysmex Corp., a leading international manufacturer of laboratory testing instruments and reagents for medical laboratories worldwide, has selected Aras Innovator PLM platform. The company will standardize product design information as electronic master data and streamline data management between development and manufacturing. The implementation will help the company meet compliance requirements for medical instrument manufacturers. Read more >>
16Nov
Skyline Medical (Formerly Known as BioDrain Medical, Inc.) Reports Third Quarter 2016 Financial Results
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three and nine months ended September 30, 2016. Read more >>
15Nov
Tiny Corbus posts midstage win–just–with resunab in systemic sclerosis
The little-known small cap Corbus Pharmaceuticals ($CRBP), last year touted as a rival to Vertex ($VRTX), has published positive top-line results from its experimental med resunab in patients with a disease that can cause major fibrosis throughout the body. Read more >>
13Nov